SCHEMBL10464804

SCHEMBL10464804

C=CC[C@@H]1CC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9406800 1.00
SCHEMBL716292 0.79 ALDH1A1 (0.38)
SCHEMBL8549913 0.77 CRBN (0.36)
SCHEMBL4551233 0.76
SCHEMBL29662768 0.74 ALDH1A1 (0.38)
SCHEMBL11096237 0.73
SCHEMBL1133788 0.73 ALDH1A1 (0.37)
SCHEMBL7624484 0.73 ALDH1A1 (0.37)
SCHEMBL11100807 0.72
SCHEMBL6687753 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4918185-A Process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones and products and starting materials therefor ELI LILLY AND COMPANY (US) 1990-04-17 US disclosed
US-4771135-A ANTIBIOTIC INTERMEDIATES ELI LILLY AND COMPANY (US) 1988-09-13 US disclosed
EP-0163452-A1 A novel process for carbon-carbon bond formation at the C-4 position of 3-acylaminoazetidinones ELI LILLY AND COMPANY (US) 1985-12-04 EP disclosed